1 |
Zhang H, Fang H, Liu D, Zhang Y, Adu-amankwaah J, Yuan J, Tan R, Zhu J. Applications and challenges of rhodopsin-based optogenetics in biomedicine. Front Neurosci 2022;16:966772. [DOI: 10.3389/fnins.2022.966772] [Reference Citation Analysis]
|
2 |
Sharif NA. Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction. J Ocul Pharmacol Ther 2022. [PMID: 36126293 DOI: 10.1089/jop.2022.0046] [Reference Citation Analysis]
|
3 |
Tran M, Kolesnikova M, Kim AH, Kowal T, Ning K, Mahajan VB, Tsang SH, Sun Y. Clinical characteristics of high myopia in female carriers of pathogenic RPGR mutations: a case series and review of the literature. Ophthalmic Genet 2022;:1-9. [PMID: 36017691 DOI: 10.1080/13816810.2022.2113544] [Reference Citation Analysis]
|
4 |
Jain A, Dokholyan NV, Lee AL. Allosteric inactivation of an engineered optogenetic GTPase.. [DOI: 10.1101/2022.05.16.490643] [Reference Citation Analysis]
|